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Abstract We have previously shown that integrin-dependent
tyrosine phosphorylation of p130Cas (Cas) could be induced in a
mouse fibroblast cell line that does not express focal adhesion
kinase p125FAK (FAK). By analyzing FAK-deficient (FAK3/3)
cells transiently expressing Cas mutant proteins, we demonstrate
here that the Src homology 3 (SH3) domain of Cas is
indispensable for adhesion-mediated Cas phosphorylation in this
mutant cell line. While the FAK directly binds to Cas-SH3, our
findings imply that SH3-binding molecule(s) other than FAK
might regulate Cas phosphorylation, at least in FAK3/3 cells.
In this regard, we observed that FAK3/3 cells expressed cell
adhesion kinase L (CAKL), a protein tyrosine kinase of the FAK
subfamily. CAKL expressed by FAK3/3 cells was associated in
vivo with Cas in a Cas-SH3-dependent manner. Moreover,
integrin stimulation induces tyrosine phosphorylation of CAKL in
FAK3/3 cells. Thus, our results suggest that CAKL contributes
to integrin-mediated signal transduction in place of FAK in FAK-
deficient cells.
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1. Introduction
The integrins are a major class of receptors used by cells to
interact with other cells and with the extracellular matrix.
Integrin-mediated adhesive interactions help regulate a variety
of fundamental biological processes including cell growth, cell
death, di¡erentiation, cell morphology and motility, and tu-
mor growth and metastasis [1,2]. Thus, integrins not only act
as simple mediators of cell adhesion but can also transduce
biochemical signals across the cell membrane [2,3]. Discovery
of a protein tyrosine kinase (PTK) that is speci¢cally localized
in focal adhesions has greatly facilitated our understanding of
integrin-mediated signal transduction [4,5]. This kinase,
termed focal adhesion kinase p125FAK (FAK), physically as-
sociates with integrins and is rapidly activated following in-
tegrin-mediated cell adhesion [1,3,5]. FAK also acts as an
adapter protein for many proteins, including Src family kin-
ases, phosphatidylinositol 3-kinase, C-terminal Src kinase
(Csk), the adapter protein Ash/Grb2, tensin, paxillin and
p130Cas (Cas) docking protein family members [3,6]. Thus,
FAK may play a central role in integrin signaling cascades
by mediating the assembly of multiple proteins into cell adhe-
sion sites and thereby propagating signals downstream.
In a previous report [7], we took advantage of mutant ¢-
broblast cell lines lacking expression of various tyrosine kin-
ases to determine their role in adhesion-dependent tyrosine
phosphorylation. This approach provided us with the unex-
pected ¢nding that integrin-mediated tyrosine phosphoryla-
tion of FAK-associated proteins, paxillin and Cas, was well
preserved in cells derived from FAK-de¢cient animals. In
sharp contrast, tyrosine phosphorylation of Cas but not of
paxillin was totally absent in c-Src-de¢cient cells. This
strongly suggested that c-Src primarily regulates Cas phos-
phorylation [7,8], while FAK is not absolutely required in
this process, at least in these mutant cells. However, this
does not necessarily discount a regulatory role for FAK in
integrin-mediated phosphorylation of Cas and paxillin in
wild-type cells. It has been suggested that there is substantial
redundancy amongst signaling molecules such as Src family
tyrosine kinases, and that when one is eliminated others may
substitute [9].
Here we demonstrate an indispensable role of the N-termi-
nal SH3 domain of Cas in inducing integrin-mediated Cas
phosphorylation. Importantly, mouse mutant ¢broblasts lack-
ing FAK (FAK3/3) expressed CAKL/Pyk2/CadTK/RAFTK,
a non-receptor PTK which belongs to the FAK subfamily
[10^13]. Like the prototype FAK, CAKL was associated
with Cas in FAK3/3 cells in a Cas-SH3-dependent manner.
Thus, CAKL appears able to functionally substitute for FAK
in integrin signal transduction and contribute to Cas phos-
phorylation in FAK3/3 cells.
2. Materials and methods
2.1. Cells and antibodies
FAK3/3 ¢broblasts were derived from mice whose FAK gene was
ablated as described [14]. Cells were maintained in Dulbecco’s modi-
¢ed Eagle medium (DMEM) supplemented with 10% fetal calf serum.
Rabbit polyclonal antibodies against Cas (anti-Cas2) were produced
as described [15]. Mouse monoclonal antibody against Cas (clone 21)
was obtained from Transduction Laboratories (Lexington, KY). Anti-
CAKL rabbit serum, anti-CAKL(N), was raised against a glutathione
S-transferase (GST) fusion protein of rat CAKL residues from 35 to
416 as described [16]. Another antibody, anti-CAKL(C), was used in
some experiments, which was raised against a GST fusion protein of
residues 670^716 of rat CAKL [16]. Anti-phosphotyrosine monoclonal
antibody (anti-pTyr), 4G10, was obtained from UBI. HA.11 is a
polyclonal rabbit antibody against the hemagglutinin (HA) epitope
and was purchased from Babco.
2.2. Transient expression of Cas mutants
Expression plasmids for in£uenza virus HA-tagged Cas (pSSRa-
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CasHA) and Cas mutant lacking the SH3 domain (pSSRa-vSH3HA)
were constructed as described previously [17]. Cells were transfected
with 10 Wg of plasmid DNA per 10 cm dish by the lipofectamine
method and were cultured for 48 h. Cells were then detached from
the dish by treating with 0.05% trypsin-EDTA, followed by washing
three times with serum-free DMEM. Cells were then used in adhesion
experiments described below.
2.3. Cell adhesion and preparation of cell lysates
Preparation of culture dishes coated with adhesive ligands, poly-L-
lysine (PLL) and ¢bronectin (FN), was described previously [6]. Cells
were plated onto dishes coated with adhesive ligands, and incubated
at 37‡C for 30 min in serum-free DMEM. Bound cells were then lysed
with 1% Nonidet P (NP)-40 lysis bu¡er as described previously. After
removing insoluble materials by centrifugation at 14 000 rpm for 10
min, protein concentrations in the supernatant were determined using
the micro BCA protein assay kit (Pierce, Rockford, IL). Cell lysates
were stored at 370‡C until use.
2.4. Immunoprecipitation and immunoblotting
Immunoprecipitation was performed according to the method de-
scribed previously [6]. In brief, cell extracts were incubated with var-
ious antibodies for 1 h at 4‡C, followed by additional incubation with
protein-G Sepharose beads for 1 h at 4‡C. Beads were then washed
5 times with 1% NP-40 lysis bu¡er to remove unbound proteins.
Immune complexes were treated with sample bu¡er, and subjected
to SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Proteins
on the gel were electrotransferred to nitrocellulose membranes, and
then subjected to immunoblotting using an enhanced chemilumines-
cence kit (Amersham, Arlington Heights, IL) as a detection system.
3. Results
3.1. The SH3 domain of Cas is essential for adhesion-dependent
Cas phosphorylation in FAK3/3 cells
In a previous study [7], we showed that Cas could undergo
tyrosine phosphorylation upon integrin-dependent adhesion in
FAK3/3 cells. Moreover, immunohistochemical examination
revealed that Cas was capable of localizing in focal adhesions
even in the absence of FAK [17]. However, when Cas lacking
the SH3 domain (vSH3-Cas) was expressed in FAK3/3 cells,
the mutant protein failed to distribute in focal adhesions [17].
Therefore, we examined whether or not the SH3 domain of
Cas was also required for Cas phosphorylation. For this pur-
pose, either wild-type Cas or vSH3-Cas, carrying an HA-epi-
tope tag, were transiently expressed in FAK3/3 cells, and
their tyrosine phosphorylation induced by cell adhesion was
examined by immunoprecipitation with anti-HA antibody. As
shown in Fig. 1A (lanes 1 and 2), cell adhesion to FN but not
to PLL induced signi¢cant increase in tyrosine phosphoryla-
tion of wild-type Cas. In contrast, vSH3-Cas failed to elicit
this response (lanes 3 and 4), although expression levels of the
mutant protein were not signi¢cantly di¡erent from those of
the wild-type Cas (lanes 1^4, lower panel). This result suggests
that the Cas SH3 domain is essential for adhesion-dependent
phosphorylation of Cas in FAK3/3 cells. In this experiment,
we also noted that the migration on SDS-PAGE of Cas ob-
tained from FN-adherent cells was slower than that obtained
from PLL-adherent cells. Increased tyrosine phosphorylation
does not account for this change in gel mobility, since vSH3-
Cas also underwent the same degree of shift in its mobility
after FN adhesion. These data suggest that Cas undergoes
post-translational modi¢cation in response to integrin stimu-
lation that is not mediated through the phosphorylation of
tyrosine.
vSH3-Cas was also expressed in NIH-3T3 cells co-express-
ing v-Src, and the level of tyrosine phosphorylation was ex-
amined by anti-pTyr immunoblotting. As shown in Fig. 1B,
lanes 1 and 2, wild-type Cas was intensely phosphorylated in
v-Src transformants, and there was no signi¢cant di¡erence in
the level of phosphorylation between cells adhered to PLL
and FN. This is consistent with our previous report [6] which
showed that the hyperphosphorylation of endogenous Cas in
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Fig. 1. Adhesion-mediated tyrosine phosphorylation of Cas is de-
pendent on the Cas-SH3 in FAK3/3 cells but not in cells trans-
formed by v-Src. A: FAK3/3 cells transiently expressing either
wild-type Cas (lanes 1 and 2) or vSH3-Cas (lanes 3 and 4), carrying
an HA epitope tag, were allowed to adhere to plates coated with
PLL (P) and FN (F) for 30 min. Cell lysates from each condition
were immunoprecipitated with anti-HA and were subjected to anti-
pTyr immunoblotting (upper panel). The same membrane was re-
probed with anti-HA immunoblotting to examine protein levels
(lower panel). B: Epitope-tagged wild-type Cas (lanes 1 and 2) and
vSH3-Cas (lanes 3 and 4) were immunoprecipitated with anti-HA
from lysates of v-Src transformants adhered to PLL (P) or FN (F)
for 30 min. The immunoprecipitates were then immunoblotted with
anti-pTyr. The same membrane was reprobed with anti-HA immu-
noblotting to examine protein levels (lower panel).
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the transformants was not a¡ected by integrin-mediated cell
adhesion. Interestingly, vSH3-Cas was also constitutively
phosphorylated regardless of cell adhesion (Fig. 1B, lanes 3
and 4). The level of tyrosine phosphorylation of vSH3-Cas
was almost comparable to that of wild-type Cas. There was
no signi¢cant di¡erence in the expression between both pro-
teins (Fig. 1B, lower panel). This suggests that hyperphos-
phorylation of Cas in v-Src-transformed cells does not require
the SH3 domain. This also indicates that vSH3-Cas used in
our experiment can be phosphorylated if appropriate stimuli
were provided. Taken together, our results suggest that SH3
domain of Cas is indispensable for adhesion-dependent Cas
phosphorylation in FAK3/3 cells. FAK, which binds the
Cas-SH3 domain, is a strong candidate for PTK regulating
adhesion-dependent phosphorylation of Cas [18]. However,
this would not explain our previous ¢ndings in FAK3/3 cells
[7]. Thus, at least in FAK3/3 cells, other molecule(s) must be
responsible for regulating Cas phosphorylation and its intra-
cellular localization.
3.2. FAK3/3 cells express CAKL, which is associated with
Cas in vivo in an SH3-dependent manner
CAKL is a recently discovered member of the FAK family
[10^13]. Di¡erences in tissue distribution and intracellular lo-
calization between FAK and CAKL suggest that these related
kinases have distinct functional properties [10,16,19]. An ini-
tial report by Sasaki et al. showed that CAKL was expressed
in rat 3Y1 ¢broblasts but not in mouse ¢broblast cell lines
[10]. Therefore, we examined our FAK3/3 cells for expres-
sion of CAKL. NP-40 lysates of 3Y1, FAK3/3 cells and
NIH-3T3 ¢broblast cells were subjected to immunoprecipita-
tion with either control or anti-CAKL(N) and immunoblotted
with anti-CAKL(N). As described, 3Y1 but not NIH-3T3 ex-
pressed CAKL (Fig. 2, lanes 2 and 6). Interestingly, a signi¢-
cant amount of CAKL was detectable in FAK3/3 cells. Anti-
CAKL(C), another antibody recognizing a di¡erent portion of
the rat CAKL, also speci¢cally immunoprecipitated mouse
CAKL from FAK3/3 cells (data not shown). These results
indicate that murine ¢broblasts from FAK-de¢cient mice ex-
press FAK-related kinase, CAKL.
CAKL contains two highly proline-rich stretches (residues
701^767 and 831^869) in the C-terminal non-kinase region
[10]. Proline-rich stretches in the FAK C-terminal domain
have been shown to bind to the SH3 domain of Cas [18].
The association between CAKL and Cas has been recently
demonstrated at low stoichiometry [20,21]. Therefore, we
next determined whether CAKL expressed by FAK3/3 cells
was associated with Cas. NP-40 cell lysates were immunopre-
cipitated with either control or anti-CAKL(N) and probed by
immunoblotting with clone 21 (monoclonal anti-Cas). It is
apparent that Cas was clearly detected only in anti-CAKL(N)
immunoprecipitates (Fig. 3A, lane 2). In parallel experiments,
we directly immunoblotted anti-Cas2 immunoprecipitates
with anti-Cas (clone 21) to determine the total amount of
Cas expressed by FAK3/3 cells (data not shown). Densito-
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Fig. 3. CAKL is associated with Cas in FAK3/3 cells in a Cas-
SH3-dependent manner. A: Lysates obtained from FAK3/3 cells
were immunoprecipitated with either control or anti-CAKL(N) anti-
bodies (lanes 1 and 2, respectively) and probed with anti-Cas2. Ly-
sates were also immunoprecipitated with either control or anti-Cas2
(lanes 3 and 4, respectively) and probed with anti-CAKL(N). B: Ly-
sates from FAK3/3 cells transiently expressing either wild-type Cas
or vSH3-Cas were immunoprecipitated with anti-CAKL(N), fol-
lowed by immunoblotting with anti-HA. The same membrane was
reprobed with anti-CAKL(N).
Fig. 2. FAK3/3 cells express CAKL. Cell lysates obtained from
3Y1 rat ¢broblasts (lanes 1 and 2), FAK3/3 cells (lanes 3 and 4),
and NIH-3T3 mouse ¢broblasts (lanes 5 and 6) were immunopre-
cipitated with either control (lanes 1, 3, and 5) or anti-CAKL(N)
(lanes 2, 4, and 6) antibodies. The immunoprecipitates were then
immunoblotted with anti-CAKL(N).
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metric analysis indicates that approximately 5% of Cas co-
precipitates with CAKL. Conversely, immunoblotting anti-
Cas2 immunoprecipitates from FAK3/3 cells also reveals
the presence of CAKL (lane 4). This indicates that in
FAK3/3 cells, an association between Cas and CAKL does
occur in vivo, at low stoichiometry.
We next examined whether or not the association between
Cas and CAKL was mediated by the SH3 domain of Cas. For
this purpose, either wild-type Cas or vSH3-Cas, carrying an
HA epitope tag, was transiently expressed in FAK3/3 cells.
Cell lysates from each transfectant were subjected to immu-
noprecipitation with anti-CAKL(N), followed by immuno-
blotting with anti-HA. As shown in Fig. 3B, wild-type Cas
but not vSH3-Cas was clearly detected in anti-CAKL(N) im-
munoprecipitates. There was no di¡erence in the amount of
CAKL immunoprecipitated from each transfectant (Fig. 3B,
lower panel). Thus, the association between Cas and CAKL
was dependent on the Cas-SH3 domain. Taken together, these
data indicate that FAK3/3 cells express FAK-related kinase
CAKL, which is associated with Cas via the Cas SH3 domain.
3.3. Integrin-dependent cell adhesion induces tyrosine
phosphorylation of CAKL in FAK-de¢cient cells
The above ¢ndings imply that CAKL is participating in
integrin-mediated signals in FAK-negative cells. We exam-
ined, therefore, if integrin-mediated cell adhesion induced ty-
rosine phosphorylation of CAKL in FAK3/3 cells. As shown
in Fig. 4, adhesion to FN-coated plates but not non-speci¢c
binding to PLL-coated plates induced a signi¢cant increase in
tyrosine phosphorylation of CAKL. Reprobing the same
membrane with anti-CAKL(N) antibody con¢rmed that the
same amounts of CAKL were loaded into each lane. This
result indicates that integrin-dependent cell adhesion induces
tyrosine phosphorylation of CAKL in FAK3/3 cells.
4. Discussion
The advent of gene ablation studies in the mouse has pro-
vided new insights into the biology of numerous molecules.
Mutant mouse embryos generated by targeting the FAK gene
displayed a general defect in mesoderm development [14]. The
overall phenotype was strikingly similar to the FN-de¢cient
phenotype [22], suggesting that FAK uniquely mediates FN-
integrin interactions in cellular processes at this stage of de-
velopment. However, ¢broblast-like cells established from mu-
tant embryos adhered well to FN and were capable of form-
ing focal adhesions in response to cell adhesion [14].
Moreover, adhesion-dependent tyrosine phosphorylation of
Cas and paxillin was well preserved even in the absence of
FAK [7,8]. These results have suggested that FAK is not
essential for organizing focal adhesion and for phosphorylat-
ing some of the major phosphotyrosyl proteins localized in
focal adhesions. In the present report, we demonstrate that
FAK3/3 cells expresses CAKL, a member of FAK-related
non-receptor tyrosine kinase subfamily. Like the prototype
FAK, CAKL was found to be associated with Cas in
FAK3/3 cells in a Cas-SH3 dependent manner. Moreover,
we also noted that tyrosine phosphorylation of CAKL was
clearly induced by adhesion of FAK3/3 cells to FN. Given
an indispensable role of the Cas-SH3 domain in integrin-
mediated Cas phosphorylation, CAKL may be able to substi-
tute the function displayed by FAK in vivo and play a role in
mediating integrin-dependent cell function in FAK3/3 cells.
Initial studies have shown that intracellular distribution was
di¡erent between FAK and CAKL [10]. While FAK is specif-
ically localized in cell-to-matrix contacts at the base of the
cells, CAKL was found to be expressed at cell-to-cell contacts
[10]. However, the later immunohistochemical analysis on var-
ious cell lines revealed that CAKL more widely distributed
within the cell. In rat ¢broblasts, most of CAKL is localized
in the cytoplasm in association with microtubules and micro-
¢laments [16]. In some other cell types, localization of CAKL
into focal adhesions was also clearly demonstrated [19,23].
Moreover, biochemical analysis showed that CAKL was asso-
ciated with paxillin and Hic-5, both of which are components
of focal adhesions [16,21,24]. Paxillin binding has been shown
to be essential for recruiting FAK to focal adhesions [25].
Recent studies by Nakamoto et al. [17] indicated that the
SH3 domain and the Src kinase binding site of Cas were
both required for targeting Cas to focal adhesions. Cas was
clearly distributed in focal adhesions in FAK3/3 cells [16].
Thus, CAKL may play a role in targeting Cas to focal adhe-
sions in FAK3/3 cells.
In summary, we showed that CAKL, a structurally FAK-
related PTK, functionally substituted for FAK in the integrin
signaling pathway in FAK3/3 cells. Nevertheless, it is ap-
parent that CAKL was not capable of substituting FAK in
mouse embryogenesis [14,22]. It is also apparent that tissue
and intracellular distribution of FAK and CAKL was distinct
[10,16,19]. Moreover, based on studies on cells which over-
express either FAK or CAKL [19], these related kinases ap-
peared to di¡erentially mediate substrate phosphorylation.
Further studies are necessary to determine di¡erential roles
of FAK and CAKL in cell functions.
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